Light Mode
$54.78 ↓ -1.08 (-1.92%) Trading Down from the previous close of $55.85, and at the day’s high of $54.78
+15.77 (+40.45%) / 6M
Momentum, market sentiment, and recent alerts
ORINY reads n/a: the 12-month move is +60.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.